The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
about
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastomaMIBG scintigraphy and PET imaging for diagnosing neuroblastomaNeuroblastomaOutcome after reduced chemotherapy for intermediate-risk neuroblastomaThe Skin as an Early Expression of Malignancies in the Neonatal Age: A Review of the Literature and a Case SeriesWhole-body MRI in paediatric oncologyChemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastomaNeuroblastoma and nephroblastoma: a radiological reviewMolecular pathogenesis of peripheral neuroblastic tumorsPlasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patientsOverview and recent advances in the treatment of neuroblastoma.Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumorsVerification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genesGlycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.Minimally invasive surgery for pediatric tumors - current state of the art.High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.Metastatic congenital neuroblastoma associated with in situ neuroblastoma: case report and review of literature.Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization.Preclinical models for neuroblastoma: establishing a baseline for treatmentClinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastomaNew aspects of neuroblastoma treatment: ASPHO 2011 symposium reviewAutoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.Epidemiological and clinical characteristics of neuroblastoma in southern iranAn Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma ChemoresistanceWhy measure tumours?Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agendaAneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 geneReverse engineering the neuroblastoma regulatory network uncovers MAX as one of the master regulators of tumor progression.Quantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma.Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.Local control in metastatic neuroblastoma in children over 1 year of ageTwo independent epigenetic biomarkers predict survival in neuroblastomaNucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation.Neuroblastoma: molecular pathogenesis and therapy.Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.Imaging in neuroblastoma: An update.Neuroblastoma progress on many fronts: the Neuroblastoma Research Symposium.
P2860
Q24186888-D99DF508-6568-408C-AA64-9900B376D830Q24234571-AF83FF54-2C5B-43E3-AB11-311AD10E18B4Q24617733-84FCD087-F569-48FC-8B66-425055088590Q24633964-E8B1D7AB-5093-4B04-9DBD-E7C25D50FABDQ26769681-40B77F11-CEA7-49D5-8AFF-498933B6CB67Q26775335-FBEC57CF-79A6-4211-A79B-CA468C38A5FAQ26800007-E49DF6C5-FAF7-4D7E-AFFA-908F67C95000Q26861867-C917B8A5-0C4F-47F7-9C2B-D070877C2BE1Q28271405-62825F4B-476A-49DA-967C-74021FEE3D63Q28304289-54C7C0FF-AD48-4735-862E-3A7F2043E73EQ30238693-C2A56DE3-8698-464C-BA51-A242648EB6F7Q31030415-255AFCA5-7FD7-4CD3-A7F4-69AA0E7411AFQ33494188-CB910C8F-1023-4FBD-A233-CFB7017C5335Q33659849-2C00E6B8-72D0-4EE9-8475-3029E94839B4Q33702533-AAD0C014-F521-4816-ADA9-28DC22FA0159Q33732709-FFFF91EC-BB62-4BA8-B1AD-B413D388F0A0Q33738022-BD7B6705-43CC-47DE-A380-3EAF35AF17FDQ33757079-4A697103-5F5C-4C9B-9DDA-1AD39570510EQ33812606-25C43CE4-BB6F-43B0-B154-98758809FC6EQ33834340-4B6AF713-8583-4883-9A8B-623FC7FFF4B0Q33870055-A00B9B4D-9694-4F15-9F18-271471EBD4C1Q33895108-8EE080DC-5B7B-4295-9934-5B9302C62773Q33914116-9D2176FC-1581-41EF-B366-ACC9A6805A0EQ33922797-1004452B-ADC0-40B9-9663-4FDC97CD4C41Q34110567-4E23140D-3C63-49FA-922A-37B2BC694832Q34234863-B534FE59-DE6D-4C8D-947B-4B29C4AD2D69Q34753903-584C21DB-AB08-4E88-B468-14C7371C90B0Q34798483-2277016F-A71E-49CE-A096-951491F5AABFQ34851245-27757A40-C542-473F-B225-575454779276Q35006926-DCE9ABBF-67AE-4ECE-9886-04CF3B26D184Q35070297-9FEC455E-54E3-41F7-AD4B-D639904524A9Q35070321-13666D8C-2428-4BC6-8AD0-AC9E340F0E5CQ35129132-ACBFBA85-1701-4B5D-BC27-32D0B5D9C799Q35146875-D606377E-C5D1-49E0-B577-01B3550E4B70Q35170598-658255DD-5A76-44D9-AB02-ECED9194C3E7Q35223869-2528FC9F-2773-4D55-A5F2-90A6EF581EC2Q35564199-4357AEF6-9D74-4279-BA97-87CA285D3287Q35565637-B7E636B3-82DE-4ADE-8609-0D810A35756AQ35568727-0183EF00-4985-4737-9929-98CC3D37CB49Q35626881-751F44B8-F94A-4C02-88F1-EB2540A29B18
P2860
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The International Neuroblastom ...... em: an INRG Task Force report.
@en
The International Neuroblastoma Risk Group
@nl
type
label
The International Neuroblastom ...... em: an INRG Task Force report.
@en
The International Neuroblastoma Risk Group
@nl
prefLabel
The International Neuroblastom ...... em: an INRG Task Force report.
@en
The International Neuroblastoma Risk Group
@nl
P2093
P2860
P50
P356
P1476
The International Neuroblastom ...... em: an INRG Task Force report.
@en
P2093
Andrew D J Pearson
Dietrich von Schweinitz
Garrett M Brodeur
Giovanni Cecchetto
Hervé J Brisse
INRG Task Force
Jed G Nuchtern
Katherine K Matthay
Keith Holmes
Michio Kaneko
P2860
P304
P356
10.1200/JCO.2008.16.6876
P407
P577
2008-12-01T00:00:00Z